CHAM
WVE icon

Clear Harbor Asset Management’s Wave Life Sciences WVE Stock Holding History

Clear Harbor Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,000
Closed -$80.5K – 400
2023
Q3 		$80.5K Sell
14,000
-21,700
-61% -$99.1K 0.01% 335
2023
Q2 		$130K Buy
+35,700
New +$144K 0.01% 330

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Clear Harbor Asset Management's WVE Position: Q4 2023 in Review

Clear Harbor Asset Management sold out of Wave Life Sciences (WVE) in Q4 2023, closing a stake of 14,000 shares — an estimated $80.5K sold.

Clear Harbor Asset Management first reported a position in WVE in Q2 2023 and held it in 2 quarters. The position peaked at $130K in Q2 2023. 115 funds tracked by Wall St. Rank hold WVE as of Q4 2023.

  • Clear Harbor Asset Management reported no remaining Wave Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Clear Harbor Asset Management sold 14,000 Wave Life Sciences shares in Q4 2023, an estimated $80.5K.
  • Clear Harbor Asset Management first reported a position in Wave Life Sciences in Q2 2023 and held it in 2 quarters.
  • Clear Harbor Asset Management's Wave Life Sciences position peaked at $130K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2023.

Based on Clear Harbor Asset Management's 13F filing for Q4 2023, filed 18 Jan 2024.